GH Research (GHRS) stock jumped 20% after-hours ahead of its Jan 5 update on Phase 3 depression program and FDA IND status on ...

The firm is betting that adding the G-quadruplex stabilizer to the ADC will improve outcomes in HER2-low breast cancer patients.

Investing.com -- East Star Resources Plc (LSE:EST) has reported positive drilling results from its Verkhuba Copper Deposit in Kazakhstan, confirming deep mineralisation and shallow extensions to the ...

Discover the junior mining firms like Northisle and Cassiar Gold that are primed for major M&A takeovers in this historic ...

EWTN News, Inc. is the world’s largest Catholic news organization, comprised of television, radio, print and digital media ...

Neither study achieved its primary endpoint of reduction in annualized clinical fracture rate compared to placebo (ORBIT) or bisphosphonates (COSMIC) Both studies achieved secondary endpoint of improv ...

Ultragenyx Pharmaceutical said on Monday that late-stage studies showed its drug for a type of genetic bone disease failed to ...

Neither study achieved its primary endpoint of reduction in annualized clinical fracture rate compared to placebo (ORBIT) or bisphosphonates (COSMIC) Both studies achieved secondary endpoint of ...

Exploring clinical development plan options including a controlled human infection model (CHIM) and a Phase 2/3 adaptive field studyExpect to ...

Janux Therapeutics, Inc. (NASDAQ:JANX) is among the Best Get Rich Fast Stocks to Buy Right Now. As of December 24, Janux ...

For decades, neurology treated the brain like a black box, nudging it with drugs and hoping symptoms would ease. Now ...

They also gave up 15 offensive rebounds, which led to 29 second chance points. If you want to calculate that it’s 1.93 points ...